Lumito strengthens its commercial position through partnership with Aurevia in advanced tissue analysis
Lumito AB (publ) ("Lumito" or the "Company") has entered into a collaboration with Aurevia AB ("Aurevia"), a CRO company specialising in clinical research and regulatory services. Through the collaboration, Lumito gains access to an additional established channel for reaching potential customers in drug development and clinical research. At the same time, Aurevia can broaden its […]
Lumito and Navinci put further collaboration on hold following promising pilot results
Lumito AB (publ) (”Lumito” or the ”Company”) has completed the pilot study with Navinci Diagnostics AB (”Navinci”) that was initiated in July 2026. The pilot study has shown promising results that strengthen Lumito’s work to verify the functionality of SCIZYS® and create conditions for increased sales. However, due to changed priorities at Navinci, the results […]
Lumito publishes investor letter
Lumito AB (publ) (”Lumito” or the ”Company”) today publishes an investor letter where the Company, among other things, follows up on the objectives that were announced in connection with the rights issue during the summer. ”We have taken clear steps forward in the commercialisation of SCIZYS. Through more qualified customer and partner discussions, progress in […]
Lumito demonstrates successful integration of SCIZYS® within automated laboratory workflow
Lumito AB (publ) ("Lumito" or the "Company") announces the successful integration of the Company's SCIZYS® Erbium kit with the automated laboratory platform for staining tissue samples from CliniSciences S.A.S (“CliniSciences”). The tests were conducted at CliniSciences using Lumito's SCIZYS® Erbium kit and produced high-quality images without prior protocol optimisation. The integration represents an important milestone […]
External study demonstrates new application areas for SCIZYS® in immunological research
Lumito AB (publ) (“Lumito” or the “Company”) highlights a recently published, peer-reviewed scientific study in which SCIZYS® has been used to analyse biomarkers in immune cells within a new research area. The study demonstrates an application of SCIZYS® in cell-based research and complements previous scientific documentation, where tissue samples have been the primary focus. The […]
Lumito receives first order outside the Nordic region
Lumito AB (publ) (“Lumito” or the “Company”) has received an order from a European university hospital. The order, valued at approximately EUR 4,000, is the Company’s first order outside the Nordic region since its commercial launch and thus marks an initial commercial step into a new geographical market. The order includes a SCIZYS Erbium Kit […]
Lumito terminates mentorship agreement
Lumito AB (publ) (“Lumito” or the “Company”) has terminated its mentorship agreement with Mangold Fondkommission AB. Under the rules of NGM Nordic SME, the obligation to appoint a mentor applies during the first two years following a listing. Lumito has been listed since autumn 2018 and considers that the mentorship is no longer necessary. The […]
Lumito publishes interim report for the second quarter of 2026
Financial overview Second quarter 2026, April 1 – June 30Net sales amounted to SEK 0 thousand (0).Profit/loss after tax amounted to SEK -10,059 thousand (-11,275).Earnings per share before and after dilution amounted to SEK -2.04 (-0.04).Cash flow from operating activities after changes in working capital amounted to SEK -4,159 thousand (-7,374). First half of 2026, […]
Lumito invites to a webinar in connection with the publication of its second-quarter 2026 report
On August 20, 2026, Lumito AB (publ) (“Lumito” or the “Company”) will publish its report for the second quarter of 2026. In connection with the publication, shareholders, investors and other interested parties are invited to a webinar on the same day at 11:00 a.m. During the presentation, Sanna Wallenborg, CEO, will provide a brief introduction […]
Lumito reports positive results from ongoing collaborative research projects – SCIZYS demonstrates high sensitivity across multiple applications
Lumito AB (publ) ("Lumito" or the "Company") today announces positive results from ongoing collaborative projects with external researchers, further strengthening the evidence supporting the Company's tissue analysis platform, SCIZYS. In a pilot project conducted together with Professor Anders Bjartell at Lund University, SCIZYS successfully identified the biomarker PSA in lymph node tissue from prostate cancer. […]